Noskapin Dak (Noscapine Hydrochloride)

Noscapine acts on the medullary cough centre in the brainstem, modulating sigma‑1 receptors and inhibiting neuronal calcium influx. This reduces the transmission of cough‑inducing signals, decreasing the sensitivity of the cough reflex while preserving normal respiratory function.

The appropriate dose of Noskapin Dak is determined by a qualified prescriber based on the patient’s condition, age, and overall health. Dosage instructions are individualized and should follow the healthcare professional’s recommendation.

Safety of noscapine hydrochloride in pregnancy and lactation has not been established. It is generally advised to avoid use during pregnancy unless the potential benefit outweighs the risk, and to exercise caution while breastfeeding, discussing options with a healthcare provider.

To order Noskapin Dak, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

The most common alternative antitussive is codeine, an opioid that can cause sedation, constipation, and dependence. Noskapin Dak, containing noscapine, offers cough suppression without opioid‑related side effects, making it a preferable option for patients who need a non‑narcotic treatment.

Store Noskapin Dak at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperatures to maintain its stability and potency throughout its shelf life.

Noskapin Dak is taken orally as directed by a healthcare professional. The tablet or oral formulation should be swallowed with water, and it may be taken with or without food depending on the prescriber’s guidance.

Serious risks, though rare, include allergic reactions such as rash, swelling, or breathing difficulties, hepatic dysfunction indicated by abnormal liver enzymes or jaundice, and severe hypotension leading to faintness or shock. Immediate medical attention is required if any of these occur.

Individuals with known hypersensitivity to noscapine or any component of the formulation should avoid Noskapin Dak. It is also contraindicated in patients where cough suppression could mask serious respiratory conditions, and caution is advised for those with severe renal impairment or on interacting medications.